Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis. [electronic resource]
Producer: 20150303Description: 1401-10 p. digitalISSN:- 1433-2965
- Absorptiometry, Photon -- methods
- Aged
- Aged, 80 and over
- Alendronate -- therapeutic use
- Alkaline Phosphatase -- blood
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Bone Remodeling -- drug effects
- Diphosphonates -- therapeutic use
- Etidronic Acid -- analogs & derivatives
- Female
- Femur Neck -- physiopathology
- Follow-Up Studies
- Hip Joint -- physiopathology
- Humans
- Lumbar Vertebrae -- physiopathology
- Medication Adherence
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Osteoporotic Fractures -- physiopathology
- Risedronic Acid
- Risk Factors
- Smoking -- adverse effects
- Treatment Failure
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.